Hana Choe, MD
Neurology · Abington, PANPI 1336301571
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,085 of the $85,938 with a category attached, or 65.3%. Stryker accounts for 62.5% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $34,002, more than ten times the $3,054 reported in 2019. Among neurology clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 232 payments — averaging $370.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$54K
- Medical Device Business Services, Inc.$22K
- Penumbra, Inc.$4K
- Johnson & Johnson$2K
- Microvention, Inc.$2K
- Medtronic$528
- plus $1K from 17 others
What the payments were for
- Consulting fees$56,08565%
- Travel & lodging$19,12622%
- Food & beverage$10,72712%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 75 | $53,676 |
| Medical Device Business Services, Inc. | 23 | $22,355 |
| Penumbra, Inc. | 21 | $4,200 |
| Johnson & Johnson | 55 | $2,492 |
| Microvention, Inc. | 19 | $1,611 |
| Medtronic(2 entities) | 10 | $528 |
| Cardiofocus, Inc. | 4 | $245 |
| Siemens Medical Solutions USA, Inc. | 1 | $170 |
| Balt USA, LLC | 1 | $92 |
| Route 92 Medical, Inc. | 1 | $89 |
| AstraZeneca | 1 | $80 |
| Sunovion Pharmaceuticals Inc. | 5 | $79 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Abbott | 2 | $44 |
| CSL Behring | 2 | $36 |
| Lundbeck LLC | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Abiomed | 1 | $26 |
| Hoffmann-la Roche Limited | 1 | $25 |
| Genentech USA, Inc. | 1 | $24 |
| Imperative Care, Inc | 1 | $21 |
| Immedica Pharma US, Inc. | 1 | $17 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURPASS EVOLVE$28,882
- EMBOGUARD$19,817
- FLOWGATE$16,275
- TREVO$12,641
- SYNCHRO SELECT$9,744
- FLOW DIVERTERS$7,024
- Penumbra System$5,267
- POWER-PRO$1,679
- WEB Aneurysm Embolization System$1,129
- STENT$804
- NEUROFORM EZ 3$669
- Embotrap$556
- Penumbra SMART Coil$550
- TRUFILL$506
- Penumbra Jet 7$401
- Cerenovus Enterprise$239
- EVOLVE$232
- ARTIS icono biplane$170
- RUBY Coil$166
- TARGET$162
How this compares
$85,938 in reported general payments places this provider in the 90th percentile of 941 neurology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 17 | $98 |
Paid to pharmacies, not to this prescriber.
Other neurology in Abington
- Brad KleinAbington$927K
- John KhouryAbington$686K
- David WeismanAbington$275K
- Daniel KremensPhiladelphia$1.8M
- Thomas LeistPhiladelphia$1.4M
- Jill Giordano FarmerPhiladelphia$1.2M
- Ravi DukkipatiYork$936K
- Stephanie Nahas-GeigerPhiladelphia$786K
- Amit Bar-OrPhiladelphia$596K
- Behrang SaminejadAllentown$594K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.